Zebrafish Vibrio Infection Models

Introduction Model Details Phenotypic Evaluation Applications Study Examples

Introduction

Vibrio species are Gram-negative pathogens responsible for a spectrum of severe diseases in both humans and aquatic animals. In humans, species such as Vibrio parahaemolyticus and Vibrio vulnificus cause acute gastroenteritis, septicemia, and severe wound infections, primarily transmitted through contaminated seafood or seawater. Vulnerable populations, including immunocompromised individuals and those with liver disease, face high mortality rates. Concurrently, species like Vibrio anguillarum cause fatal vibriosis in aquaculture, resulting in devastating economic losses globally.

Current treatments heavily rely on broad-spectrum antibiotics; however, the rapid emergence of antimicrobial resistance (AMR) poses a significant challenge to global public health. There is an urgent need to discover novel antibacterial agents and understand the precise mechanisms of infection. Zebrafish Vibrio infection models have emerged as a powerful translational platform. Due to their fully developed innate immune system during early embryonic stages, zebrafish models allow researchers to evaluate antibacterial efficacy, investigate host-pathogen interactions, and screen immunomodulatory compounds in a biologically relevant in vivo system.

Why Zebrafish?

Optical Transparency: Enables real-time, non-invasive imaging of fluorescently labeled bacteria and immune cell dynamics.
Conserved Immunity: Possesses an innate immune system (macrophages and neutrophils) highly homologous to mammals.
High Throughput: High fecundity and small size allow for rapid, cost-effective screening of antibacterial libraries.
Fast Pathology: Rapid disease progression yields reliable survival and efficacy data within days.

Available Zebrafish Disease Models

We provide a suite of species-specific and infection-route configurations covering major human and aquaculture Vibrio pathogens:

Model Name	Induction Method	Features
Zebrafish Vibrio cholerae Intestinal Colonization Model	Larval zebrafish are exposed to V. cholerae by immersion or controlled colonization protocols.	Commonly used to study intestinal colonization, host-microbiome interaction, virulence factors, and anti-colonization therapies.
Zebrafish Vibrio alginolyticus Infection Model	Zebrafish larvae, juveniles, or adults are challenged with V. alginolyticus by immersion or injection.	Produces robust survival and bacterial burden readouts; suitable for evaluating anti-Vibrio compounds, host immunity, and metabolic interventions.
Zebrafish Vibrio anguillarum Vibriosis Model	Larvae or juvenile zebrafish are infected by bath immersion or microinjection with defined bacterial doses.	Relevant to aquaculture vibriosis; supports testing of phages, vaccines, probiotics, immunostimulants, and protective interventions.
Zebrafish Vibrio parahaemolyticus Infection Model	Zebrafish are infected by immersion or systemic challenge depending on the study objective.	Useful for studying seafood-borne Vibrio pathogenesis, multidrug-resistant strains, antimicrobial efficacy, and pathogen clearance.

Phenotypic Evaluation

Host Immune and Inflammatory Response

Inflammatory cytokine expression, such as il1b, tnfa, il6, and cxcl8
Neutrophil and macrophage recruitment
ROS and oxidative stress markers
Antimicrobial peptide or innate immune gene expression

Therapeutic Efficacy and Safety

Survival rescue after treatment
Reduction of bacterial load
Dose-response and treatment-window analysis
General toxicity and developmental safety endpoints

Disease Severity and Survival

Survival rate and Kaplan–Meier survival curve
Dose-response or LD50 assessment
Gross morphology and edema scoring
Behavioral activity or swimming impairment

Bacterial Colonization and Clearance

CFU-based bacterial burden quantification
Fluorescent bacterial imaging
Tissue dissemination or intestinal colonization
Pathogen clearance after treatment

Key Applications

Anti-Vibrio Drug Discovery: In vivo screening and validation of antibiotics, natural products, antimicrobial peptides, and small molecules.
Phage Therapy Evaluation: Assessment of prophylactic and therapeutic phage efficacy against Vibrio colonization or systemic infection.
Aquaculture Disease Research: Modeling vibriosis caused by V. anguillarum, V. alginolyticus, and V. parahaemolyticus.
Virulence Mechanism Studies: Analysis of toxins, secretion systems, motility, biofilm-related genes, and strain-specific pathogenicity.
Host Immunity and Microbiome Research: Investigation of innate immune activation, inflammatory signaling, intestinal colonization, and microbiota shifts.
Vaccine, Probiotic, and Immunostimulant Testing: Preclinical evaluation of protection, bacterial clearance, and host immune modulation.

Study Examples

Metabolic modulation improves zebrafish survival after V. alginolyticus infection. The authors established a zebrafish V. alginolyticus infection model to investigate whether metabolic intervention could improve host survival. Zebrafish were challenged with V. alginolyticus and treated with malate or taurine-related metabolic modulation. Results indicated that malate enhanced resistance to infection and helped regulate excessive immune responses, supporting the use of zebrafish for anti-Vibrio efficacy testing and host-directed therapy research.

Fig. 1. Malate treatment improves survival of zebrafish infected with V. alginolyticus (Yang MJ, Xu D, et al., 2020).

Accelerate Your Vibrio Infection Research with Zebrafish Models

Accelerate your infectious disease research and anti-infective drug discovery programs with our standardized, high-throughput zebrafish models. Our dedicated team of scientists offers customizable study designs tailored to your specific therapeutic goals.

Contact Our Scientists

Reference

Yang MJ, Xu D, et al. Malate enhances survival of zebrafish against Vibrio alginolyticus infection in the same manner as taurine. Virulence 11(1), 349–364 (2020).

For research use only. Not intended for any clinical use.